VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
92,076
AK1,880
AL6,345
AR4,151
AS46
AZ14,991
CA66,887
CO12,550
CT8,943
DC1,795
DE2,009
FL42,724
FM4
GA17,031
GU124
HI2,580
IA4,919
ID2,892
IL22,128
IN24,197
KS5,047
KY9,111
LA5,500
MA15,718
MD13,434
ME3,351
MH8
MI20,971
MN13,585
MO10,747
MP30
MS3,198
MT2,477
NC18,051
ND1,501
NE3,109
NH3,218
NJ20,216
NM4,218
NV4,728
NY37,667
OH20,793
OK6,692
OR9,244
PA25,607
PR2,588
QM2
RI2,163
SC7,261
SD1,282
TN10,445
TX39,890
UT4,618
VA15,980
VI67
VT1,830
WA16,071
WI12,042
WV2,571
WY926
XB5
XL1
XV2

ID: 1183922
Sex: M
Age:
State: KS

Vax Date: 03/22/2021
Onset Date: 03/23/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; Body aches; Light headed; Loss of energy; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old male patient reported for himself that he received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: Pfizer er8730, Expiration date: unknown) via an unspecified route of administration on 22Mar2021 at 13:00 on left arm at single dose for COVID-19 Immunization. Medical history included Chrones. The concomitant medication was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 23Mar2021 16:00 (24-hour clock), patient experienced headache, body aches, Lightheaded and Loss of energy. The patient did not receive any treatment for the events. The reporter assessed the event as non-serious. The events were not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1183923
Sex: F
Age:
State: OH

Vax Date: 03/02/2021
Onset Date: 02/09/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headaches; migraines; Light and noise sensitivity.; noise sensitivity; This is a spontaneous report from a contactable consumer or other non hcp. A 43-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Right on 02Mar2021 05:15 (Batch/Lot Number: EL9269) as single dose for covid-19 immunisation. Medical history included hashimotos thyroid, drug hypersensitivity, food allergy unknown if ongoing, drug hypersensitivity from unknown if ongoing, allergies to medications, food, or other products Cipro, doxycycline. Concomitant medication(s) included sertraline hcl (ZOLOFT) taken for an unspecified indication, start and stop date were not reported; alprazolam (ALPRAZOLAM) taken for an unspecified indication, start and stop date were not reported. On 09Feb2021 the patient experienced headaches, migraines, light and noise sensitivity, noise sensitivity. The outcome of the events was not recovered.

Other Meds: Zoloft; ALPRAZOLAM

Current Illness:

ID: 1183924
Sex: M
Age:
State: NJ

Vax Date:
Onset Date:
Rec V Date: 04/09/2021
Hospital: Y

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tested positive; tested positive; This is a spontaneous report reported by a contactable consumer regarding a male patient. A contactable consumer (Reporter's father) reported for an unspecified age male patient received first dose of BNT162B2 (formulation: Solution for injection, lot number: unknown, Expiration date; unknown), unspecified route of administration on unspecified date at 0.3 mL, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient did not have allergies. Reporter father was hospitalized and tested positive a week after taking the 1st dose of Covid-19 vaccine on unspecified date, father doesn't have an appointment also for the 2nd dose and he would like to know also how long do they need to wait to get the 2nd dose of his father. The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1183925
Sex: F
Age:
State:

Vax Date: 03/24/2021
Onset Date: 03/25/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Nausea; vomiting; This is a spontaneous report from a non-contactable consumer (Patient herself). A 38-year-old non-pregnant female received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EN6203, Expiration Date: Unknown) via an unspecified route of administration in the left arm at SINGLE DOSE for COVID-19 Immunization in the workplace clinic. The patients medical history included colitis and IBD (Inflammatory bowel disease) from an unknown date and unknown if ongoing. The patient had no allergies to medications, food or other products. Concomitant medication included Mesalamine. The patient previous received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 02Mar2021 for COVID-19 Immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and not tested after vaccination. The patient experienced nausea and vomiting approximately 22 hours and again 28 hours after receiving vaccine on 25Mar2021 at 08:00. Follow-up action is closed, further information is cannot be obtained.

Other Meds: MESALAMINE

Current Illness:

ID: 1183926
Sex: M
Age:
State:

Vax Date: 03/08/2021
Onset Date: 03/01/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: contracted Covid; he contracted Covid in between the doses; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection) via an unspecified route of administration on 08Mar2021 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient received his first dose of the Pfizer Covid Vaccine last 08Mar2021 and would be receiving his 2nd dose on 29Mar2021. However, he contracted Covid in between the doses and would come off from isolation on 28Mar2021 and would be released to work on 29Mar2021. Wanted to know if it's ok to get his second dose. The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1183927
Sex: F
Age:
State: PA

Vax Date: 03/17/2021
Onset Date: 03/01/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: diagnosed with COVID-19/tested positive for COVID; diagnosed with COVID-19/tested positive for COVID; she was tired; This is a spontaneous report from a contactable consumer (patient). This consumer reported similar events for two patients. This is the first of two reports. A 58-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot and expiry were not reported), via an unspecified route of administration in left arm on 17Mar2021 06:40 (at the age of 58-years-old) as single dose for covid-19 immunisation. The patient received first dose of bnt162b2 (lot: EL9266) in left arm on 22Feb2021 at about 07:30 (at the age of 58-years-old) for covid-19 immunisation. The vaccination facility type was stated that was like a wellness center, an urgent care, hospital clinic and the vaccine was not administered at military facility. No additional vaccines administered on same date of the Pfizer suspect. No prior vaccinations (within 4 weeks). There were no primary infection site, no predisposing factors, no culture performed and no antipyretic Use (around the date of vaccination). Medical history included did not have the best immune system and has some vitamin deficiencies. Concomitant medication included bamlanivimab. The patient's second vaccine was 23 days after the first vaccine. The patient received the second dose on 17Mar2021 and tested positive 20Mar2021 for the Covid virus. The patient stated that her husband tested positive for the Covid virus as well. The patient asked if she will need to get another vaccine. This Saturday (20Mar2021 at 18:00), they were diagnosed with COVID-19 and they were currently still battling it. The patient got the result on 20Mar2021 at 18:00, and describes as it got worse, but then it plateaued. The patient wanted to know if having COVID-19 at the time of vaccination lessen the efficacy of the vaccine. The patient wanted to know if she should take another shot because she has COVID-19 at the time of vaccination. The patient was not going to fill out her husband's report, she was tired. The height reported as 5 foot 1 and a half. The events did not require emergency room visit, no hospitalization as of yet. They gave her monoclonal antibodies at the Urgent Care. They scheduled that at the Urgent Care. The outcome of the events was unknown. Information about lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021336109 same reporter/drug/event, different patient

Other Meds: BAMLANIVIMAB

Current Illness:

ID: 1183928
Sex: F
Age:
State: TN

Vax Date: 03/23/2021
Onset Date: 03/24/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: allergic reaction; Rash; This is a spontaneous report from a contactable consumer (patient). A 20-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 23Mar2021 (Batch/Lot number: EN6207) at single dose (at 20-year-old) in arm right for COVID-19 immunization. Medical history was reported as none. Ongoing concomitant medication included galcanezumab (EMGALITY injection) monthly; and ethinylestradiol/ norethisterone acetate (HAILEY) daily; both for an unspecified indication from an unspecified date. The patient got the vaccine on 23Mar2021 (Tuesday), then noticed the rash on 24Mar2021 (Wednesday) evening about 9 pm it started in chest and abdomen and over the last couple of days it spread down to some of arms and legs. It's a mild rash over a decent part of her body. She believed it's an allergic reaction frankly. She had been taking diphenhydramine hydrochloride (BENADRYL). She was taking it three times now over the last Wednesday. The rash was still there (persisting).

Other Meds: EMGALITY [GALCANEZUMAB]; HAILEY 1.5/30

Current Illness:

ID: 1183929
Sex: F
Age:
State: OH

Vax Date: 03/14/2021
Onset Date:
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: feeling weak; she feels like she can hardly stand/I felt weak like I couldn't even stand up; tingling in the back of her neck as well; This is a spontaneous report from a contactable consumer reported for herself. A 68-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 14Mar2021 at single dose for COVID-19 immunisation. Medical history included auto-immune disorder. Concomitant medications were not reported. The patient stated she had been feeling weak, she felt weak when standing up, and she felt like she can hardly stand. She had been feeling this way for the past 2 weeks. However, it seems like it's getting better today. She felt tingling in the back of her neck as well. She just wanted to know after the first vaccine does anybody got weak 'legs and hand overall (not clear nor clarified). Patient just wondered if she should even get the second shot, she didn't know if it had to do anything with it or 'if it's not'. Patient added she had autoimmune disease, so that's why she was wondering. The outcome of events was unknown. Information for lot number/batch number has been requested.

Other Meds:

Current Illness:

ID: 1183930
Sex: F
Age:
State: CA

Vax Date: 03/21/2021
Onset Date: 03/24/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: severe vertigo started Wednesday morning and still have it and can't stand up; This is a spontaneous report from a contactable consumer (patient). A 43-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 21Mar2021 16:45 (Batch/Lot Number: ER8730) at the age of 43-years-old as single dose for covid-19 immunisation. Medical history reported as none. The patient's concomitant medications were none. Patient was not pregnant. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. She experienced side effects 3 days after the administration of the first dose of the Pfizer's COVID-19 vaccine she experienced severe vertigo started Wednesday morning and still have it and can't stand up on 24Mar2021. Adverse event result in Doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of severe vertigo included Meclazine RX. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the events was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1183931
Sex: M
Age:
State:

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Upset stomach 2 days after 1st COVID vaccine shot; This is a spontaneous report received from a non-contactable consumer (Patient). A 33-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on an unknown date in Mar2021 (Batch/Lot Number: ER2613) at the age of 33-years-old as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The patient experienced upset stomach 2 days after 1st covid vaccine shot on an unknown date in Mar2021. The outcome of the event unknown. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1183932
Sex: M
Age:
State: CO

Vax Date: 03/25/2021
Onset Date: 03/26/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pain at injection site; lightheadedness/dizzy; lethargic; This is a spontaneous report from a contactable consumer (patient). A 65-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Right on 25Mar2021 12:15 (Batch/Lot Number: UNKNOWN) at the age of 65-years-old as single dose for covid-19 immunisation. The COVID-19 vaccine was administered at Public Health Clinic. Medical history included Peanut oil allergy. Concomitant medications included lisinopril taken for an unspecified indication, start and stop date were not reported; rosuvastatin taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient took the first dose of bnt162b2 for covid-19 immunization on 04Mar2021 12:15 PM at Left arm. The patient experienced pain at injection site, lightheadedness/dizzy, lethargic on 26Mar2021 10:30. No treatment received for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the events recovering. Information on the lot/batch number has been requested.

Other Meds: LISINOPRIL; ROSUVASTATIN

Current Illness:

ID: 1183933
Sex: F
Age:
State: IL

Vax Date: 03/25/2021
Onset Date: 03/26/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Injection site soreness; Aches and tiredness starting about 24 hours after injection; Aches and tiredness starting about 24 hours after injection.; This is a spontaneous report from a contactable consumer (patient). A 41-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 25Mar2021 11:30 (Batch/Lot Number: EK5730) at the age of 41-years-old as single dose for covid-19 immunisation. The COVID-19 vaccine was administered at Workplace clinic. Patient was not pregnant. Medical history included High Blood Pressure, Hypoparathyroidism, allergies to Penicillin, Bleach. The patient concomitant medication included unspecified medication within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162B2 (lot number: EJ1685) at left arm on 04Mar2021 11:00 AM for covid-19 immunisation. The patient experienced injection site soreness, aches and tiredness starting about 24 hours after injection on 26Mar2021 11:00 AM. No treatment received for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the events was recovering.

Other Meds:

Current Illness:

ID: 1183934
Sex: F
Age:
State: NJ

Vax Date: 03/25/2021
Onset Date: 03/25/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: chills; sweats; tired; This is a spontaneous report received from a contactable consumer (patient). A 54-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 25Mar2021 10:00 (Batch/Lot Number: EP6955) at the age of 54-years-old as single dose for covid-19 immunisation. Patient was not pregnant. Medical history included hypertension, osteo-arthritis. Concomitant medications included candesartan cilexetil (ATACAND) taken for an unspecified indication, start and stop date were not reported; vitamin B2 [riboflavin] taken for an unspecified indication, start and stop date were not reported; vitamin D2 taken for an unspecified indication, start and stop date were not reported; ubidecarenone (COQ10) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received first dose of BNT162B2 (Lot number: EL3247) on 03Mar2021 10:00 AM at left arm for covid-19 immunization. The patient had chills and sweats and was really tired on 25Mar2021 07:30 PM. No treatment received for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the events was recovering.

Other Meds: ATACAND; VITAMIN B2 [RIBOFLAVIN]; VITAMIN D2; COQ10 [UBIDECARENONE]

Current Illness:

ID: 1183935
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: having memory issues from her stroke; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as a single dose for COVID-19 immunization. Medical history included stroke. The patient's concomitant medications were not reported. On an unspecified date, the patient was having memory issues from her stroke. She had her stroke a while ago, but was still unable to recall when, only stating that it was before her vaccination. Outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1183936
Sex: M
Age:
State: PA

Vax Date:
Onset Date: 03/20/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: diagnosed with COVID-19/tested positive for COVID; diagnosed with COVID-19/tested positive for COVID; This is a spontaneous report from a contactable consumer (patient's wife). This consumer reported similar events for two patients. This is the second of two reports. A 47-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) on an unspecified date and received the second dose on 15Mar2021 (at the age of 47-year-old), both via an unspecified route of administration at SINGLE DOSE for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On 20Mar2021, the patient was diagnosed with COVID-19 and currently still battling it. The consumer further reported that her husband had his second dose last week, on Monday (15Mar2021), and hers was given on Wednesday. She reported that they both tested positive for COVID on 20Mar2021, after, and they are still trying to beat it. The consumer wanted to know if having COVID-19 at the time of vaccination lessen the efficacy of the vaccine. The patient had not yet recovered from the events. Information about lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021335455 same reporter/drug/event, different patient

Other Meds:

Current Illness:

ID: 1183937
Sex: F
Age:
State:

Vax Date: 03/26/2021
Onset Date: 03/26/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Extreme tiredness; sweating; confusion; This is a spontaneous report received from a non-contactable consumer (patient herself). A 38-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in arm left on 26Mar2021 10:00 (lot number: unknown) as single dose for covid-19 immunisation. Prior to vaccination, the patient was diagnosed with COVID-19. Pregnant at the time of vaccination was no. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient's concomitant medications were not reported. The patient experienced extreme tiredness extreme tiredness, sweating and confusion on 26Mar2021 with outcome of not recovered. No treatment was received for events. Since the vaccination, the patient had not been tested for COVID-19. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1183938
Sex: F
Age:
State: NJ

Vax Date: 03/11/2021
Onset Date: 03/13/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I began to bleed and pass blood clots from my vagina; I began to bleed and pass blood clots from my vagina; This is a spontaneous report from a contactable consumer (patient). A 32-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in the left arm on 11Mar2021 01:15 (at the age of 32 years) (Batch/Lot Number: EN6208) as a single dose for COVID-19 immunisation. Medical history included birth control. Concomitant medications were not reported. The patient is not pregnant. On 13Mar2021 04:00, the patient began to bleed and pass blood clots from her vagina. The event blood clots was assessed as serious (medically significant). The patient visited the doctor for the events and the events were given treatment. The outcome of the events was not recovered.

Other Meds:

Current Illness:

ID: 1183939
Sex: M
Age:
State:

Vax Date: 03/21/2021
Onset Date: 03/27/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tiredness; headache; slight numbness of right side of face; slight loss of muscle control in right side of face; This is a spontaneous report received from a non-contactable consumer (patient). A 35-year-old male patient received first dose of bnt162b2 (Batch/Lot Number: 953738), at the age of 35-year-old via an unspecified route of administration, administered in left arm on 21Mar2021 as single dose for covid-19 immunization. Medical history included high blood pressure from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient experienced tiredness, headache, slight numbness of right side of face, slight loss of muscle control in right side of face all on 27Mar2021 16:00. No treatment received for the adverse events. The events were reported as non-serious. The adverse event was not resulted in a visit to doctor or other healthcare professional office/clinic or Emergency room/department or urgent care. Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hadn't been tested for COVID-19. Not allergies to medications, food, or other products. The outcome of events was not resolved.

Other Meds:

Current Illness:

ID: 1183940
Sex: F
Age:
State: NY

Vax Date: 03/20/2021
Onset Date: 03/21/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: severe seasonal allergy symptoms; Headache; Extended migraine. severe intermittent aural effects (loss of vision, shots of light, looks snow on a TV); tingling in limbs- hands, toes, left side of face; This is a spontaneous report received from a contactable consumer (patient). This 39-year-old female patient (no pregnant ) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in left arm on 20Mar2021 14:00 (Lot Number: ER8727) at single dose for COVID-19 immunization. Medical history included allergy: allergies to medications, food, or other products was not known. Concomitant medications included ascorbic acid, cobalt sulfate, copper sulfate, ergocalciferol, ferrous fumarate, magnesium sulfate, manganese sulfate, nicotinamide, potassium iodide, pyridoxine hydrochloride, retinol, riboflavin, thiamine hydrochloride, tocopherol, vitamin b12 nos, zinc gluconate (MULTIVITAMIN (16)); oenothera biennis oil (EVENING PRIMROSE); cetirizine for allergy. The patient experienced severe seasonal allergy symptoms, headache, extended migraine with severe intermittent aural effects (loss of vision, shots of light, looks snow on a TV) tingling in limbs, hands, toes, and left side of face on 21Mar2021 at 23:45. Symptoms had come and go 10 and more times a day, but seemed to be decrease in frequency and severity lessening. The patient was not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was no diagnosed with COVID-19. Since the vaccination, the patient not been tested for COVID-19. Seriousness criteria: results in death, life threatening, caused/prolonged hospitalization, disabling/incapacitating, congenital anomaly/birth defect was no. Treatment received for the adverse events included Tylenol. The outcome of the events was recovering.

Other Meds: MULTIVITAMIN (16); EVENING PRIMROSE; CETIRIZINE

Current Illness:

ID: 1183941
Sex: M
Age:
State: CA

Vax Date: 03/25/2021
Onset Date: 03/25/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever/temperature was 99.6/ 99.4 /99.3; This is a spontaneous report from a contactable consumer. A 78-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) dose 2 via an unspecified route of administration on 25Mar2021 09:00 (Batch/Lot Number: ER8732; Expiration Date: 31Jul2021) as single dose for covid-19 immunisation. Medical history included heart valve replacement from 13Nov2019 to an unknown date (His heart operation was 13Nov2019 it has been 16 months that he has been inactive), chronic myeloid leukaemia from 2018 to an unknown date, accumulating fluid around the lung sack from an unknown date and unknown if ongoing aortic stenosis (from an unknown date and unknown if ongoing (They changed the heart valve because he had aortal stenosis), heart murmur from an unknown date and unknown if ongoing (He went in to see his general practitioner and a woman there said he had a heart murmur) cough from an unknown date and unknown if ongoing (Caller states he has a little cough. He quit smoking several years ago and has been coughing ever since. The cough was prior to COVID-19 vaccines) fell from Nov2020 to an unknown date (Caller fell the first week of Nov2020 and that is how long the process has taken. He has been in pain for months. Caller clarified that his hospitalizations and fall were prior to getting the vaccine). The patient previously took first dose of bnt162b2 for covid-19 immunisation and sprycel and experienced kidneys were failing. (Caller clarified that the hospitalization he had for 8 days was when he was on Sprycel and he was hospitalized because his kidneys were failing). Caller clarified that he has a fever, but he is not sure what it is because of the thermometer. Earlier today it was 99.6. It is now 2:24PM (State name) time, so it has been 5.5 hours since the vaccine on 25Mar2021. His temperature was 99.6 then 99.4 then 99.3. Frankly he doesn't trust it. He had positive experience both times he got the COVID Vaccine. The patient underwent lab tests and procedures which included body temperature: 99.6 on 25Mar2021 body temperature: 99.4 on 25Mar2021 body temperature: 99.3 on 25Mar2021 white blood cell count: unknown results on (When he went to the doctor to get checked he had unusual white blood cells running). The outcome of the event was reported as unknown. No follow up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1183942
Sex: F
Age:
State:

Vax Date: 02/12/2021
Onset Date: 02/01/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: administration date 12Feb2021/administration date 26Jan2021; administration date 12Feb2021/administration date 26Jan2021; had breakthrough bleeding for the first time ever. Periods were significantly heavier with massive clots; This is a spontaneous report from a non-contactable consumer (patient). A 37-year-old female patient (not pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3249 and expiration date not provided), via an unspecified route of administration, in left arm, on 12Feb2021 10:00 (at the age of 37-year-old, not pregnant), at single dose, for COVID-19 immunization. Medical history was not reported. Patient has no known allergies to medications, food, or other products. Patient was not diagnosed with COVID-19 prior to vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No concomitant medication (reported as "patient received no medications within 2 weeks of vaccination"). The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), via an unspecified route of administration, in left arm, on 26Jan2021 (at the age of 37-year-old), at single dose, for COVID-19 immunization. In Feb2021 and Mar2021 patient had breakthrough bleeding for the first time ever. Periods were significantly heavier with massive clots. Patient saw OBGYN, but no reason found except vaccine side effect. Event result in doctor or other healthcare professional office/clinic visit. No treatment received. Patient had not been tested for COVID-19 since the vaccination. The outcome of the events was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1183943
Sex: M
Age:
State: ME

Vax Date: 03/24/2021
Onset Date: 03/25/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Felt like passing out at 12:30p the next afternoon; temperature of 95 degrees; Headaches; fatigue; dizziness; minor chest pain; shortness of breath; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number: ER8727), via an unspecified route of administration in left arm on 24Mar2021 16:30 PM (at the age of 29-years-old) as a single dose for COVID-19 immunization. Medical history was not reported. Concomitant medications were not reported. Prior to vaccination, patient diagnosed with COVID-19. On 25Mar2021 at 12:30 PM, the patient experienced felt like passing out, temperature of 95 degrees, headaches, fatigue, dizziness, minor chest pain and shortness of breath. Felt like passing out at 12:30 PM the next afternoon, temperature of 95 degrees at that time and experienced headaches, fatigue, dizziness, minor chest pain and shortness of breath since that day. The patient did not receive any treatment for the events. The clinical outcomes of the felt like passing out, temperature of 95 degrees, headaches, fatigue, dizziness, minor chest pain and shortness of breath were resolved with sequel. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1183944
Sex: F
Age:
State:

Vax Date: 03/10/2021
Onset Date: 03/01/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: this past Saturday, she tested positive; This is a spontaneous report from a patient reported for herself. An 49-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6202) via unknown route first dose on 10Mar2021, at an unknown dose, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient received the 1st dose covid vaccine on 10Mar2021. She has tested negative for covid infection every Saturday since then. However, this past Saturday (Mar2021), she tested positive. She is scheduled to receive the 2nd dose of the covid vaccine on 31Mar2021. Patient would like to know whether she can get the 2nd dose of the covid vaccine although she has tested positive for covid after the 1st dose. Patient would like to know if she still has to wait the isolation period (10 days) before returning for her second dose if she tests negative tomorrow. The outcome of the event was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1183945
Sex: F
Age:
State: FL

Vax Date: 02/19/2021
Onset Date: 03/11/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: called back to schedule her second appointment but is was past 42 days so they said she could not schedule; tested positive for Covid/Got COVID; tested positive for Covid/Got COVID; Tiredness; achiness; This is a spontaneous report from a contactable consumer. A 68-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in left arm on 19Feb2021 13:00 (at the age of 68 years) (Batch/Lot Number: EN6200) as a single dose to prevent getting COVID (COVID-19 immunization). Ongoing medical history included high blood pressure (started about 10 years ago) and varicose vein (At least probably about 20 years). Family history includes both of her parents had heart problems, Mother had a stroke (she doesn't know when, she took medications for heart problems) and Father died of a heart attack. Concomitant medications included hydrochlorothiazide taken for hypertension. It was reported that the patient had the first dose on 19Feb2021 and was due to have second dose on 13Mar2021 and two days before that (11Mar2021) she ended up being sick having symptoms (cold) so she had to cancel the appointment and was tested for COVID. On 17Mar2021 the patient found out she got COVID. She called back to schedule her second appointment but is was past 42 days so they said she could not schedule. It was reported that she was not sure when she had COVID-19, it would have been in the evening when she started feeling like she had a cold. She's still having a little bit of tiredness since 11Mar2021 but no cough. Her tiredness is not as bad now. The patient also experienced achiness on an unspecified date in 2021. The patient received the following treatment for the events: Vitamin C, not sure if helped, Vitamin D, not sure if helped, and Advil, helped with achiness. The outcome of the event tiredness was not recovered, while unknown for the rest of the events.

Other Meds: HYDROCHLORZIDE

Current Illness: Blood pressure high (Verbatim: high blood pressure/Started about 10 years ago.); Varicose veins (Verbatim: Varicose veins/At least probably about 20 years)

ID: 1183946
Sex: M
Age:
State: SC

Vax Date: 03/24/2021
Onset Date: 03/24/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: double pneumonia; body aches/I started aching; headache; tired/fatigue/exhausted; I got the chills; my skin felt like it was sunburned; cough; fog; no appetite; sweating; my arm hurt/sore arm; he had a previous flu like symptoms after the shingles vaccine.; This is a spontaneous report from a contactable consumer (Patient). A 56-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- ER8727), via an unspecified route of administration in the left arm on 24Mar2021 at 10.30 (at the age of 56-years-old) as single dose for covid-19 immunisation. Medical history included hypertension diagnosed 20 years ago, blood cholesterol diagnosed about 7 years ago, Covid-19 in Dec2020 which hit him pretty hard, double pneumonia, he was wiped out, patient had a shingles vaccine a couple of years ago he had a fever and it felt like he had the flu, for about 48 hours he was wiped out. This happened with both doses of the shingles vaccine. Concomitant medication(s) included colecalciferol (VITAMIN D [COLECALCIFEROL]) and vitamin C (ascorbic acid) (VITAMIN C [ASCORBIC ACID]). On 24Mar2021 (Wednesday), patient experienced double pneumonia, body aches/i started aching, my arm hurt, headache, tired/fatigue/exhausted, i got the chills, my skin felt like it was sunburned, cough, fog, no appetite, sweating, sore arm, he had a previous flu like symptoms after the shingles vaccine. It was reported that all the same symptoms the patient had with COVID, the caller had after the vaccine. The next morning was much worse and through that next day. Patient describes his side effects like a mini Covid 19 reaction. The symptoms were very similar to the symptoms he had 4 days into his Covid-19 diagnosis. It was reported that on Friday (26Mar2021) he felt normal and was able to workout on Saturday (27Mar2021) as usual. The patient believes his antibodies are strong following his virus and then the 1st Pfizer vaccine dose. The patient doesn't think he had a fever, but he didn't have that with covid along with no loss of taste and smell. The patient was very grateful for the vaccine. Patient had no other vaccinations within 4 weeks prior vaccination. The patient underwent lab tests which included blood cholesterol and blood pressure whose results are reported as high on an unknown date. The outcome of the event double pneumonia was unknown, and for all other events it was recovered.

Other Meds: VITAMIN D [COLECALCIFEROL]; VITAMIN C [ASCORBIC ACID]

Current Illness:

ID: 1183947
Sex: F
Age:
State: CA

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 04/09/2021
Hospital: Y

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: She found out on 09Jan2021 her results for Covid was positive; This is a spontaneous report from a contactable consumer via Medical Information Team. A female patient of an unknown age received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- UNKNOWN) via an unspecified route of administration in an unspecified anatomical location on 08Jan2021 as single dose for covid-19 immunization. Relevant medical history and concomitant medications were not reported. The patient was tested for covid on 04Jan2021 and 07Jan2021 with results unknown. The patient found out on 09Jan2021 positive for covid-19 after receiving the first dose on 08Jan2021. The patient was hospitalized on 16Jan2021 to 22Jan2021 for 6 days, during the time patient received the infusions for Covid. The events were considered serious due to hospitalization and medically significant. The outcome of the events covid-19 and drug ineffective was unknown. The patient was asking for 90 days to be okay or will she need to restart the vaccination series. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1183948
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: bit by a deer tick; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number and expiry date unknown), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose of BNT162B2 on an unspecified date for COVID-19 immunization. It was reported that after the patient got her second vaccine, she was bit by a deer tick and stated that they carry Lyme disease. The patient was prescribed doxycycline and wanted to know if it was compatible with the vaccine that she received the day before. The outcome of the event was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1183949
Sex: U
Age:
State: PA

Vax Date:
Onset Date:
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: in Jan2020 I suspect (not confirmed) I had covid; in Jan2020 I suspect (not confirmed) I had covid; illness; developed a rash on the trunk of my body; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received bnt162b2 (Solution for injection), dose 1 via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. In Jan2020 patient suspect (not confirmed), had Covid. During patient illness developed a rash on the trunk of body. Now patient received second Covid vaccination on Wednesday afternoon and woke up this morning with a much milder version of the same rash (same location and pattern). Suspect patient had Covid in Jan2020 but that was before testing so not confirmed. No concomitant meds or underlying conditions. Event took place after use of product. The events "in Jan2020 I suspect (not confirmed) I had covid" were considered as medically significant. The outcome of the events was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1183950
Sex: F
Age:
State: NC

Vax Date: 03/05/2021
Onset Date:
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pain in the left arm/Having pain in left arm; when I lift my arm up it's like; my arm is just trembling all the time; pain in the back of her neck; Nerve is jerking, it's so jittery; When I try to make a muscle it's like annoying to me; This is a spontaneous report received from a contactable 68-year-old female patient reported for himself that she received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/lot number: EN6201, expiration date: 02May2021), via an unspecified route of administration on 05Mar2021 at single dose for covid-19 immunization. The patient's relevant medial history included she had a surgery on 13nov2019 to thyroid nodules taken out. Historical vaccine included bnt162b2 for covid-19 immunization on 25Jan2021 (1st Dose of Covid-19 vaccine Taken, LOT#: EN5318). Concomitant medications included levothyroxine sodium for thyroid disorder. On an unknown date, the patient had pain in the left arm/having pain in left arm; when i lift my arm up it's like and her arm was just trembling and all the time pain in the back of her neck, nerve was jerking, it was so jittery, when she tried to make a muscle it was like annoying to the patient. The patient took Tylenol 500 mg Twice daily for the events. The patient stopped taking Tylenol as it was not working and it was really giving her pains in my stomach, so the patient tried to switch to Advil or Aleve. The outcome of the events was unknown. No follow-up attempts are needed. No further information is expected

Other Meds: LEVOTHYROXINE SODIUM

Current Illness:

ID: 1183951
Sex: F
Age:
State: FL

Vax Date: 03/24/2021
Onset Date: 03/01/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: diarrhea; This is a spontaneous report received from a Pfizer sponsored program . A Contactable consumer (patient his wife) reported that a female patient of an unspecified age received bnt162b2 (BNT162B2; Solution for injection), dose 2 via an unspecified route of administration on 24Mar2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient previously received first single dose of bnt162b2 on 03Mar2021 for Covid-19 immunization. It was reported he mentioned that his wife had a reaction with Pfizer vaccine like diarrhea in Mar2021, and he added that he experienced a pain in his arm where the vaccine injected. The outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021349483 Different patient, same drug, different event

Other Meds:

Current Illness:

ID: 1183952
Sex: M
Age:
State: NJ

Vax Date: 03/29/2021
Onset Date: 03/30/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chills; fatigue; dehydration; trouble sleeping and staying asleep; trouble sleeping and staying asleep; headache; This is a spontaneous report from a contactable consumer (patient). A 21-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EP7533), via an unspecified route of administration, in Left arm on 29Mar2021 at 12:15 PM (at the age of 21-years-old) at a single dose for COVID-19 immunization. Medical history included asthma. The patient's concomitant medications were not reported. The patient previously took Wellbutrin and experienced allergies. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EN6206), via an unspecified route of administration, in Left arm on 08Mar2021 at 01:15 PM at a single dose for COVID-19 immunization. No other vaccine was given in four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination has not been tested for COVID-19. The patient experienced chills, fatigue, dehydration, trouble sleeping and staying asleep and headache from 30Mar2021 at 05:00 AM. No treatment was given for the events. The outcome of the events was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1183953
Sex: F
Age:
State: IL

Vax Date: 03/29/2021
Onset Date: 03/29/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Vomiting; Severe headache; This is a spontaneous report from a contactable consumer reported for self. A 35-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration as single dose in Left arm on 29Mar2021 12:00 AM (Lot number: ER8733) for COVID-19 immunisation. No pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient's medical history was not reported. Prior to vaccination, the patient did not diagnose with COVID-19. Concomitant medications included escitalopram oxalate (LEXAPRO) and amfetamine aspartate/amfetamine sulfate/dexamfetamine saccharate/dexamfetamine sulfate (ADDERALL), both received within 2 weeks of vaccination. The patient experienced vomiting and Severe headache on 29Mar2021 07:00 PM, there was no treatment received. Since the vaccination, the patient had not been tested for COVID-19. Outcome of the events was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds: LEXAPRO; ADDERALL

Current Illness:

ID: 1183954
Sex: M
Age:
State: DE

Vax Date: 03/18/2021
Onset Date: 03/01/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever; Chills; Sever headache; Nausea; diarrhea; Felt extremely tired; This is a spontaneous report received from a contactable consumer (patient) from a Pfizer sponsored program. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), dose 1 via an unspecified route of administration on 18Mar2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. Medical history included covid-19 in Dec2020. The patient's concomitant medications were not reported. On an unknown date in Mar2021, the patient experienced fever, chills, sever headache, nausea, diarrhea and felt extremely tired. The events were considered as non-serious. The patient underwent lab tests and procedures which included Covid-19 test in Dec2020 which shows positive results. The outcome of the event felt extremely tired was recovered after 24 hours, whereas outcome of rest all events was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained

Other Meds:

Current Illness:

ID: 1183955
Sex: M
Age:
State: CA

Vax Date: 03/18/2021
Onset Date: 03/28/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Full body rash, not at injection site, 10 days after 2nd vaccine shot; This is a spontaneous report from a contactable consumer (patient). A 56-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number was EP6955), via an unspecified route of administration, administered on right arm on 18Mar2021 (at the age of 56-years-old) at a single dose for COVID-19 immunization. Medical history included high blood pressure. Patient had no allergies to medications, food or other products; was not diagnosed with COVID-19 prior vaccination. Concomitant medications included lisinopril, hydrochlorothiazide, vitamin b, c, d and zinc within 2 weeks of vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN6205) administered on 24Feb2021 at 10:00 AM on right arm, single dose for COVID-19 immunization. The patient had most recent COVID-19 vaccine at Pharmacy or Drug Store. The patient experienced full body rash, not at injection site on 28Mar2021 08:00, 10 days after second vaccine shot. The event resulted in doctor or other healthcare professional office/clinic visit. No treatment was given for the event. The patient underwent lab tests and procedures which included nasal swab test COVID-19 test which had a negative result on 29Mar2021. The outcome of the event was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds: LISINOPRIL; HYDROCHLOROTHIAZIDE; VITAMIN B; VITAMIN C [ASCORBIC ACID]; VITAMIN D [COLECALCIFEROL]; ZINC

Current Illness:

ID: 1183956
Sex: F
Age:
State: NY

Vax Date: 02/26/2021
Onset Date: 03/21/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tested positive for Covid after receiving the first dose of the vaccine; Tested positive for Covid after receiving the first dose of the vaccine/she is very fatigued but that is from the Covid; This is a spontaneous report received from a contactable consumer (patient). A 67-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EN6202), via an unspecified route of administration on 26Feb2021 at single dose for covid-19 immunization. Medical history included high Blood Pressure and high cholesterol. Concomitant medications included losartan at a dose of 50mg per day; takes 25mg in morning and 25mg in evening for blood pressure, rosuvastatin calcium (CRESTOR) at a dose of 5mg once a day for cholesterol. Both the concomitant medications started a few years ago. The patient received her first covid vaccine dose on 26Feb2021 and she was supposed to get her second dose on 26Mar2021 but she got sick with COVID on 21MAR2021 and tested positive for COVID on 22MAR2021 but she thought her symptoms were there before a little bit. The patient asking that if she can have her second dose of the covid vaccine after 42 days if she had Covid following her first dose. It was reported that she was told to be at home for ten days, no repeat test. Patient was very fatigued but that was from the COVID, not her vaccine, that was over a month ago. Patient declines to complete the supplemental form at this time; she states that she is getting tired and would like to be transferred at this time. At the time of this report event outcome was unknown. Follow-up attempts are needed. Further information is expected.

Other Meds: LOSARTAN; CRESTOR

Current Illness: High cholesterol (Additional Information for Other Conditions: Doesn't remember how long ago she was diagnosed.); Hypertension (Additional Information for Other Conditions: Doesn't remember how long ago she was diagnosed.)

ID: 1183957
Sex: F
Age:
State: IL

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tightness in throat; "fuzzy" feeling in my head; This is a spontaneous report from a contactable consumer reported for self. A 33-year-old female patient (No pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 30Mar2021 14:45 (Lot Number: ER8734) as single dose for covid-19 immunisation. Medical history included diagnosed with COVID-19 Prior to vaccination. Allergies to medications, food, or other products: Cephalexin. The patient's concomitant medications were not reported. The patient reported that she was experiencing tightness in throat and "fuzzy" feeling in head on 30Mar2021 15:00 with outcome of unknown. All events considered non-serious. No treatment received for the events. Since the vaccination, the patient did not been tested for COVID-19. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1183958
Sex: F
Age:
State:

Vax Date: 03/24/2021
Onset Date: 03/25/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever of 101 degrees; Mild pain at injection site; Muscle pain (legs); This is a spontaneous report from a contactable consumer (patient). A non-pregnant 50-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCCINE; Lot Number: EN6199), via an unspecified route of administration in left arm, on 24Mar2021 at 16:45 (04:45 PM), at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took cefalexin (CEPHALEXIN) as antibiotic and experienced allergies; and the first dose of BNT162B2 (Lot Number: EN6205) on 03Mar2021 at 05:00 PM in left arm for COVID-19 immunization. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 25Mar2021 at 02:45 AM approximately 10 hours after shot, the patient experienced mild pain at injection site and muscle pain (legs) (also reported as on 24Mar2021 at 22:00) that were increasing until approximately 30 hours after shot. On 25Mar2021 at 10:45 PM approximately 18 hours after shot, the patient had fever of 101 degrees (also reported as on 24Mar2021 at 22:00). All reactions cleared by 36 hours after shot. The events were considered non-serious. No treatment was received for the adverse events. Since the vaccination, the patient has not been tested for COVID-19. The patient recovered from the events on 26Mar2021 at 04:45 AM.

Other Meds:

Current Illness:

ID: 1183959
Sex: F
Age:
State: CO

Vax Date: 01/22/2021
Onset Date: 03/30/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tested positive for COVID on 30Mar2021 09:00; tested positive for COVID on 30Mar2021 09:00; This is a spontaneous report received from COVAES from a contactable nurse (patient). A 45-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose via an unspecified route of administration, administered in left arm on 31Dec2020 09:15 (Lot Number: EK9231) as single dose, second dose via an unspecified route of administration, administered in left arm on 22Jan2021 09:00 (Lot Number: EL8982) as single dose for covid-19 immunisation. Medical history included allergies to sulfa. The patient received other medications within 2 weeks. Patient was no pregnant at the time of vaccination. The vaccine was administered at hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The adverse event result in doctor or other healthcare professional office/clinic visit. Treatment was not received for the adverse event. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient underwent rapid Covid test twice for COVID-19 on 22Mar2021 with result of negative. Reporter reported that tested positive for COVID on 30Mar2021 09:00. The event outcome for events was recovering.; Sender's Comments: Based on the information currently available, vaccination failure with the suspected vaccine BNT162B2 in this patient cannot be completely excluded. Further information like confirmative virus genome /nucleic acid detection is needed for meaningful medical assessment.

Other Meds:

Current Illness:

ID: 1183960
Sex: F
Age:
State:

Vax Date: 03/10/2021
Onset Date: 03/01/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: she was positive with the corona virus; sinus infection; This is a spontaneous report received from Pfizer sponsored program. A non-contactable consumer (patient) reported that a female patient of an unspecified age started to receive first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection) via an unspecified route of administration on 10Mar2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient received vaccine first dose on 10Mar2021 and then when she thought she had sinus infection. They tested her and on 23Mar2021, she was positive with the corona virus. She is scheduled for the second dose of vaccine on 31Mar2021. She is asking if she can still get this. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1183961
Sex: F
Age:
State: MI

Vax Date:
Onset Date:
Rec V Date: 04/09/2021
Hospital: Y

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: she fell when she came home; tested positive for COVID; tested positive for COVID; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient fell when she came home and had to go to the hospital when she was there she tested positive for COVID, the patient had the first dose of the vaccine then tested positive for COVID. Her next shot was due on 02Apr2021 (Friday). The outcome was unknown. Information about Lot/Batch number is requested.

Other Meds:

Current Illness:

ID: 1183962
Sex: F
Age:
State:

Vax Date: 03/11/2021
Onset Date: 03/27/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: She received her first Pfizer Covid vaccine dose on 11Mar2021 diagnosed with Covid-19 on 27Mar2021; She received her first Pfizer Covid vaccine dose on 11Mar2021 diagnosed with Covid-19 on 27Mar2021; This is a spontaneous report from a contactable consumer reporting on herself. A 39-years-old female patient received first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiration date was not reported), via an unspecified route of administration on 11Mar2021 as SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that patient was diagnosed with COVID-19 on 27Mar2021. She is due for her second dose on 01Apr2021. She wants to know if she can get her second dose of the vaccine or does she need to wait. The patient underwent lab test which included COVID-19: positive on 27Mar2021. Seriousness of the events was medically significant. Outcome of the events was unknown. Information on the batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 1183963
Sex: F
Age:
State: NC

Vax Date: 03/20/2021
Onset Date: 03/01/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: joint pain which started in the knee then shoulder and hands; left knee lock; This is a spontaneous report from a Pfizer Sponsored Program . A contactable female consumer (patient) reported that a female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 20Mar2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received Pfizer Covid-19 vaccine first dose last 20Mar2021 and she experienced joint pain which started in the knee then shoulder and hands on an unknown date in Mar2021. The next morning, she experienced left knee lock. Her 2nd dose will be on 10Apr2021 and she wanted to know if she needed to delay the appointment for the 2nd dose. The outcome of the events was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1183964
Sex: F
Age:
State: FL

Vax Date: 01/09/2021
Onset Date: 01/18/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: got the 1st dose of COVID-19 vaccine on 09Jan2021 and her 2nd dose was supposedly scheduled on 30Jan2021/advised by the facility that she needs to wait 90 days to get the 2nd dose; got the 1st dose of COVID-19 vaccine on 09Jan2021 and her 2nd dose was supposedly scheduled on 30Jan2021/advised by the facility that she needs to wait 90 days to get the 2nd dose; positive with Covid-19; This is a spontaneous report from a contactable consumer (patient) via a Pfizer-sponsored program,. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration, on 09Jan2021, as single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient got the 1st dose of COVID-19 vaccine on 09Jan2021 and her 2nd dose was supposedly scheduled on 30Jan2021; however, on 18Jan2021 (9 days after getting the 1st dose), she got positive with COVID-19. The patient's concern was to reschedule her 2nd dose because she was advised by the facility that she needs to wait 90 days to get the 2nd dose due to being positive with COVID-19. The outcome of the event COVID-19 was unknown. Information about batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 1183965
Sex: F
Age:
State:

Vax Date: 03/10/2021
Onset Date: 03/01/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tested positive for COVID-19; tested positive for COVID-19; This is a spontaneous report from a contactable consumer (patient son) reported for a female (mother) patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number and Expiration dates were unknown), via subcutaneous route of administration, on 10Mar2021 as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It reported that, the consumers mom (patient) received first dose of the COVID-19 vaccine on 10Mar2021. The patient tested positive for COVID-19 after COVID-19 vaccine. She was scheduled to take the second dose of the vaccine on 31Mar2021. However, her doctor recommends to postpone the second dose of the vaccine since she has COVID-19. The patient underwent lab tests and procedures which included SARS-COV-2 test: positive on an unspecified date. The outcome of the patient event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1183966
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Drug ineffective; contracted Covid with complications after receiving vaccine; This is a spontaneous report received from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: UNKNOWN Expiration date: UNKNOWN), via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced contracted covid with complications after receiving on an unspecified date. The patient underwent lab tests and procedures which included SARS-COV-2 test was contracted covid with complications on an unspecified date. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1183967
Sex: F
Age:
State: MO

Vax Date:
Onset Date:
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tested positive for Covid; tested positive for Covid; This is a spontaneous report from a contactable consumer (patient). A female patient of an unknown age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date were not reported) via an unspecified route of administration on an unknown date at SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medication were not reported. On an unknown date, the patient was tested positive for Covid. She received a BAM fusion after testing positive and was not sure if she can get 2nd dose after receiving BAM fusion. The outcome of the events was unknown. The patient underwent lab tests and procedures which included SARS-CoV-1 test which was positive on an unknown date. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1183968
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tested positive for covid after first shot; Tested positive for covid after first shot; This is a spontaneous report from a non-contactable consumer or other non hcp (patient). A male patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. It was reported that the patient got first dose of vaccine. Tested positive for covid after first shot. The patient was advised by his HCP to quarantine for 10 days, ending on 31Mar2021, and proceed to get second shot on 01Apr2021. Wanted to know if he should wait another week before getting second shot or if getting it on 01Apr2021 was okay. Outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1183969
Sex: F
Age:
State: FL

Vax Date: 03/05/2021
Onset Date: 03/01/2021
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Stomach pain; Diarrhea; This is a spontaneous report from a contactable consumer or other non hcp (patient) from a Pfizer-sponsored program. A female patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 05Mar2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. It was reported that the patient had her first shot on 05Mar2021 and was due to get her second dose tomorrow. She mentioned that she currently had stomach pain and diarrhea. The patient would like to know if it is okay for her to take the second dose. Outcome of the events was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1183970
Sex: F
Age:
State: PA

Vax Date:
Onset Date:
Rec V Date: 04/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tested positive with Covid; tested positive with Covid; This is a spontaneous report from a contactable consumer (patient) reported that a female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got her first dose of the vaccine but she got tested positive with COVID on an unspecified date. The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1183971
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 04/09/2021
Hospital: Y

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: acute hemolytic anemia; she developed DIC; Hbg was 6.0; This is a spontaneous report from a contactable physician. A 51-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) solution for injection, dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for Covid-19 immunisation. Medical history included ongoing Wilson's disease, copper overload syndrome (taken Penicillamine for decades). Concomitant medication included ongoing penicillamine taken for Wilson's disease and copper overload syndrome. The patient was admitted to the hospital last week with a life-threatening illness. After multiple tests the physician believed it was related to patient's 1st dose of the vaccine. She had acute hemolytic anemia and her HBG was 6.0. The physician also stated patient developed DIC (disseminated intravascular coagulation). She was transfused with 3 units of blood due to adverse reactions and improved. She then received 2 more units of blood and was steadily improving. The patient has a history of Wilson's disease, copper overload syndrome, and has taken Penicillamene for decades, which can cause hemolysis. The patient was still taking this medication and was still getting better. This patient was due for her 2nd dose soon. The physician will defer to a later date. The physician would like to request if there was any information/data regarding hemolysis, DIC associated with the vaccine. The events were reported as life-threatening. Patient was admitted to hospital in Mar2021 due to the events. Multiple tests done in Mar2021 with unknown result. Outcome of the events was recovering. Information on lot/batch number has been requested.; Sender's Comments: Due to a plausible drug-events temporal association, the company cannot completely exclude a contributory role of vaccine BNT162b2 administration in the development of the reported, serious events: "hemolytic anemia and disseminated intravascular coagulation, with HBG 6.0, as consequence of anemia. The impacts of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds: PENICILLAMINE

Current Illness: Copper (taken Penicillamene for decades); Wilson's disease (taken Penicillamene for decades)

Total 2021 VAERS Injuries: 704,237

Page last modified: 03 October 2021 5:28pm